Total Payments
$6,326
2024 Payments
$610.85
Companies
37
Transactions
361
Medicare Patients
16,589
Medicare Billing
$830,200
Payment Breakdown by Category
Food & Beverage$6,246 (98.7%)
Consulting$60.00 (0.9%)
Education$20.07 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,246 | 358 | 98.7% |
| Consulting Fee | $60.00 | 1 | 0.9% |
| Education | $20.07 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,456 | 83 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $807.74 | 49 | $0 (2024) |
| AbbVie Inc. | $505.02 | 31 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $351.36 | 19 | $0 (2024) |
| Amarin Pharma Inc. | $328.13 | 18 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $288.70 | 15 | $0 (2022) |
| GlaxoSmithKline, LLC. | $270.33 | 13 | $0 (2024) |
| Amgen Inc. | $269.36 | 15 | $0 (2024) |
| Lilly USA, LLC | $263.75 | 16 | $0 (2024) |
| Mylan Specialty L.P. | $238.07 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $610.85 | 31 | Novo Nordisk Inc ($191.52) |
| 2023 | $752.84 | 35 | Novo Nordisk Inc ($168.17) |
| 2022 | $871.64 | 45 | Novo Nordisk Inc ($266.04) |
| 2021 | $1,002 | 60 | AbbVie Inc. ($208.52) |
| 2020 | $771.03 | 42 | AstraZeneca Pharmaceuticals LP ($152.41) |
| 2019 | $879.55 | 56 | Novo Nordisk Inc ($152.29) |
| 2018 | $748.96 | 45 | Novo Nordisk Inc ($237.77) |
| 2017 | $689.24 | 47 | Novo Nordisk Inc ($119.19) |
All Payment Transactions
361 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.23 | General |
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $24.22 | General |
| Category: Cardiovascular | ||||||
| 10/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/16/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.62 | General |
| 10/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.15 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: VACCINES | ||||||
| 09/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.53 | General |
| Category: Obesity | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: Diabetes | ||||||
| 08/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $24.30 | General |
| 07/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Diabetes | ||||||
| 07/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: RESPIRATORY | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/27/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.05 | General |
| 06/18/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: VACCINES | ||||||
| 06/06/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/15/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.61 | General |
| Category: Cardiovascular | ||||||
| 05/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: UROLOGY | ||||||
| 04/04/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,010 | 5,640 | $486,692 | $222,140 |
| 2022 | 37 | 4,082 | 5,623 | $491,132 | $207,145 |
| 2021 | 39 | 4,347 | 6,102 | $532,129 | $220,474 |
| 2020 | 35 | 4,150 | 5,747 | $489,841 | $180,441 |
Total Patients
16,589
Total Services
23,112
Medicare Billing
$830,200
Procedure Codes
142
All Medicare Procedures & Services
142 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 248 | 248 | $55,825 | $33,192 | 59.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 273 | 274 | $60,554 | $31,990 | 52.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 108 | 109 | $32,700 | $30,738 | 94.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 264 | 447 | $51,466 | $27,139 | 52.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 218 | $38,150 | $20,484 | 53.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 149 | 150 | $11,250 | $10,704 | 95.1% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 24 | 523 | $34,518 | $9,812 | 28.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 27 | $9,342 | $6,182 | 66.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 329 | 626 | $13,772 | $5,258 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 149 | 150 | $4,800 | $4,673 | 97.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 307 | 410 | $23,780 | $4,244 | 17.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 276 | 289 | $24,276 | $3,792 | 15.6% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 21 | 23 | $5,658 | $3,629 | 64.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 313 | 462 | $16,632 | $3,516 | 21.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 212 | 367 | $23,488 | $3,494 | 14.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 108 | 109 | $3,488 | $3,418 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 69 | 79 | $6,004 | $3,104 | 51.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 99 | 103 | $12,360 | $2,988 | 24.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 121 | 132 | $11,880 | $2,173 | 18.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $2,825 | $1,894 | 67.0% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 85 | 85 | $8,160 | $1,608 | 19.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 39 | 42 | $4,536 | $1,395 | 30.7% |
| 97161 | Evaluation for physical therapy, typically 20 minutes | Office | 2023 | 14 | 17 | $2,550 | $1,317 | 51.7% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 24 | 24 | $3,240 | $973.20 | 30.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 42 | 47 | $4,512 | $846.94 | 18.8% |
About Dr. Lawrence Weiner, M.D
Dr. Lawrence Weiner, M.D is a Internal Medicine healthcare provider based in Niles, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508816901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Weiner, M.D has received a total of $6,326 in payments from pharmaceutical and medical device companies, with $610.85 received in 2024. These payments were reported across 361 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,246).
As a Medicare-enrolled provider, Weiner has provided services to 16,589 Medicare beneficiaries, totaling 23,112 services with total Medicare billing of $830,200. Data is available for 4 years (2020–2023), covering 142 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Niles, IL
- Active Since 05/10/2006
- Last Updated 12/15/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508816901
Products in Payments
- Ozempic (Drug) $530.56
- Vascepa (Drug) $328.13
- FARXIGA (Drug) $319.54
- JARDIANCE (Drug) $277.11
- XARELTO (Drug) $225.77
- SYMBICORT (Drug) $181.51
- INJECTAFER (Drug) $175.40
- Saxenda (Drug) $167.41
- NURTEC ODT (Drug) $166.79
- UBRELVY (Drug) $166.50
- ENTRESTO (Drug) $165.67
- Yupelri (Drug) $159.55
- Rybelsus (Drug) $158.47
- Victoza (Drug) $147.43
- CHANTIX (Drug) $140.40
- Aimovig (Biological) $131.67
- SYNTHROID (Drug) $121.54
- BREZTRI (Drug) $112.36
- JANUVIA (Drug) $105.93
- SHINGRIX (Biological) $104.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Niles
Dr. Ramona Sheth, M.d.,, M.D.,
Internal Medicine — Payments: $21,982
Internal Medicine $21,982
Dr. Sanjay Sheth, M.d, M.D
Internal Medicine — Payments: $17,755
Internal Medicine $17,755
Basem Doss, Md, MD
Internal Medicine — Payments: $12,848
Internal Medicine $12,848
Dr. Peter Sargon, M.d, M.D
Internal Medicine — Payments: $7,824
Internal Medicine $7,824
Dr. Bahaa Awadalla, M.d, M.D
Internal Medicine — Payments: $7,824
Internal Medicine $7,824
Dr. Heba Mikhail, M.d, M.D
Internal Medicine — Payments: $7,463
Internal Medicine $7,463